Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
|
|
Oxford Immunotec Global PLC (OXFD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2020 |
4
| BALTHROP PATRICK J (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Bought 4,000 shares
@ $12.48, valued at
$49.9k
|
|
| 05/12/2020 |
4
| Wrighton-Smith Peter (CEO) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Bought 2,075 shares
@ $10.75, valued at
$22.3k
Bought 26,000 shares
@ $11.45, valued at
$297.7k
Bought 15,525 shares
@ $11.56, valued at
$179.5k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Wrighton-Smith Peter (CEO) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 62,087 shares
@ $0
Granted 62,087 options to buy
@ $12.19, valued at
$756.8k
|
|
| 11/20/2019 |
4
| Kidd Janet Louise (General Counsel) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 11,207 shares
@ $0
Granted 25,612 options to buy
@ $16.73, valued at
$428.5k
|
|
| 11/05/2019 |
4
| SANDBERG RICHARD A (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 3,000 shares
@ $15.6, valued at
$46.8k
Exercised 1,650 options to buy
@ $0.09, valued at
$148.5
Exercised 1,350 options to buy
@ $8.65, valued at
$11.7k
|
|
| 10/03/2019 |
4
| Wrighton-Smith Peter (CEO) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 30,000 shares
@ $16.2134, valued at
$486.4k
|
|
| 09/25/2019 |
4
| Wrighton-Smith Peter (CEO) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 20,000 shares
@ $14.9183, valued at
$298.4k
Sold 80,000 shares
@ $17.0137, valued at
$1.4M
|
|
| 08/20/2019 |
4
| Wrighton-Smith Peter (CEO) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 10,000 shares
@ $13.8647, valued at
$138.6k
|
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| Walton Andrew Scott (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.44, valued at
$107.7k
|
|
| 06/19/2019 |
4
| TOBIN JAMES R (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.44, valued at
$107.7k
|
|
| 06/19/2019 |
4
| SANDBERG RICHARD A (Director) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Granted 7,457 options to buy
@ $14.44, valued at
$107.7k
|
|
|
|
|